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MR DWIAbstract Objective: To evaluate the value of color Doppler, tri-phasic CT and Diffusion weighted
magnetic resonance imaging in differentiating benign from malignant portal vein thrombosis.
Patients and methods: This study included 50 patients presented ultrasonically with PVT referred
for discriminating the benign from malignant PVT. The color Doppler US, tri-phasic CT and
MR DWI results were compared and correlated with available histopathological results.
Results: Those 50 patients were classiﬁed on the bases of imaging criteria and histopathology into
two groups: G.(I) included 17 patients with benign PVT and G.(II) included 33 patients with malig-
nant PVT. Intrathrombus pulsatile ﬂow was depicted in 25 patients with malignant PVT (25/33). On
tri-phasic CT, neovascularity and early arterial enhancement of PVT were depicted in 28/33 and
29/33 of malignant cases and non-depicted in benign cases with 100% speciﬁcity. ADC values
for group I was mean + SD (1.1 ± 0.1), median (1.2), and the ADC values for group II was
mean + SD (0.7 ± 0.1), median (0.8) with signiﬁcant P value (0.001). ROC curve revealed cutoff
value (61), sensitivity (100%), speciﬁcity (82.5%).
Conclusion: Distinguishing benign from malignant PVT is required to determine the management
plane. The combination of color Doppler US, tri-phasic CT and MR DWI is essential for more
accurate evaluation and can obviate FNAC.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Portal vein thrombosis (PVT) indicates thrombosis that devel-
ops in the trunk of the portal vein including its right and leftintrahepatic branches. It either occurs in association with
cirrhosis or malignancy of liver or may happen without an
associated liver disease (1,2).
It is important to differentiate between benign and malig-
nant PVT to determine the management plan (3). The presence
of neoplastic thrombus serves as an important determinant of
tumor staging, as well as prognosis, and inﬂuences treatment
selection (4–7).
It is important to remember that most hepatic vascular dis-
orders are often not suspected clinically and are only diag-
nosed by imaging studies due to non-speciﬁc clinical and
Table 1 Real time ultrasound and color Doppler ﬁndings of
our 50 patients.
Real time US
ﬁnding
Group I
Benign cases (17)
Group II
Malignant cases (33)
No. of
patients
(%) No. of
patients
(%)
Liver cirrhosis
Present 15 88.23 33 100
Absent 2 11.76 0 0
Hepatic mass
Solitary 15 45.45
Multicentric 18 54.54
Hypoechoic 6 18.18
Iso to Hyper echoic 10 30.30
Heterogeneous 17 51.51
Spleen
Splenomegaly 11 64.7 31 93.9
No Splenomegaly 6 35.2 2 6.06
Ascites
Absent 6 35.29 13 39.39
Mild 9 52.94 10 30.30
Moderate 2 11.76 5 15.15
Marked 0 0 5 15.15
Color Doppler findings
PV thrombus
Main PV 17 100 27 81.81
Right Branch 3 17.6 17 51.51
Left branch 1 5.8 4 12.12
Intra thrombus flow
Pulsatile ﬂow 0 0 25 75.75
No pulsatile ﬂow 17 17 8 24.24
Table 2 Triphasic CT ﬁndings of our 50 patients.
Triphasic CT ﬁnding Group I
(benign cases)
N= 17
Group II
(malignant
cases) N= 33
P
value
(1) PVT Triphasic CT characteristics
(i) Neovascularization
of the thrombus
0 (0%) 28 (84.84%) 0.004
(ii) Arterial
enhancement with
rapid washout
0 (0%) 29 (87.87%) 0.004
(iii) Direct invasion by
adjacent hepatic mass
0 (0%) 25 (75.75%) 0.004
(iv) Diameter of the
thrombus >23
0 (0%) 25 (75.75%) 0.002
(2) Hepatic focal lesion CT characteristics
(i) Solitary 0 3 (9.09%) 0.1
(ii) Multi-centeric 0 28 (84.84%) 0.007
(iii) Diﬀuse 0 2 (6.06%) 0.1
(iv) Early arterial
enhancement with
rapid washout
0 33 (100%) 0.009
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lar lesions (8).
The reference standard for characterizing portal vein
thrombus is histopathological examination. However, in
clinical practice, diagnostic imaging such as Doppler ultra-
sonography, contrast-enhanced computed tomography, and
MRI imaging, together with clinical and laboratory ﬁndings
is often relied upon for thrombus discrimination (9).
Color Doppler imaging is often the initial technique of
choice for the noninvasive assessment of abnormalities of the
portal veins. The use of Doppler US in diagnosis of malignant
PVT has been evaluated by several studies as non-visualization
of portal venous ﬂow and pulsatile ﬂow in the thrombus (10).
Tri-phasic CT of the liver, using early, late arterial and
portal venous phases with ﬁxed time delays is quick, easy
and non-invasive useful imaging modality in detection and
characterization of the focal lesions and especially the diagno-
sis of HCC in cirrhotic patients and non-invasively diagnosed
PVT and CTPV. However the accuracy of tri-phasic CT scan
in diagnosis of PVT, exposure to ionizing radiation and hyper-
sensitivity to contrast media remains major obstacle compared
to color Doppler US (11).
Recent reports have highlighted the potential of diffusion-
weighted (DW) imaging to differentiate benign from malignant
liver lesions (12–14). A recent study concluded that quantita-
tive measurements from diffusion-weighted imaging (DWI)
were highly accurate in differentiating these entities (13).
2. Patients and methods
This study was approved by the ethics committee of our insti-
tution. This study was carried out on 50 patients referred to the
Radiology Department with sonographic evidence of portal
vein thrombosis at the period from March 2014 to February
2015. All patients in this study were subjected to the following:
The patient included in this study according the following
criteria:
Inclusion criteria: (1) Patients with chronic hepatic disease
and PVT. (2) Patients with non-cirrhotic liver presenting with
PVT.
Exclusion criteria: (1) Liver biopsy contraindication:
increased prothrombin time, international organized ratio
(INR) greater than 1.6; (2) Patients with impaired renal func-
tions or terminal liver failure; (3) Pregnancy; (4) The presence
of any other malignancies, such as gonadal or gastric
malignancies, that may elevate the AFP levels; and (5) the
patients with persistent hypotension unresponsive to ﬂuid
resuscitation.
All patients were subjected to the following:
(1) Thorough history taking including: Special habits e.g.
alcoholism present history of hematemesis or melena,
jaundice, exposure or intake of hepatotoxic drugs, previ-
ous local alcohol injection or any other local ablation
for hepatic focal lesion.
(2) Clinical examination including: general examination
stressing on jaundice and the consciousness level and
local abdominal examination, with stressing on liver,
spleen, ascites and collaterals.
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albumin, prothrombin activity, tumor markers including
serum alpha fetoprotein and anti-HBV and anti-HCV.3. Radiological examination includes
3.1. (A) Real-time ultrasound
The abdominal ultrasound was done with 3.5 MHz
transducer for examination of the liver as regards its size,
echotexture, contour, hepatic focal lesion, PV patency, the
presence or absence of intrahepatic biliray radicles dilata-
tion, porta-hepatis, abdominal lymph nodes and presence
of ascites. Also spleen, splenic hilum and pancreas were
evaluated.
3.1. (B) Color Doppler ultrasound study of the portal vein
Color Doppler examination was performed using (Logic P5
General Electric medical system, Milwaukee, WI, USA) Ultra-
sound machine using 3.5 MH matched imaging and DopplerFig. 1 Male patient 38 y old presented by attack of hematemesis
thrombosed PV (red arrow) and dilated portal radicles (cavernous tra
arterial phase and (D) Coronal porto-venous-phase revealed thrombosfrequency transducer. The protocol consisted of obtaining
gray-scale image of PV thrombus and performing color, power
and duplex Doppler US for PV thrombus, PV tributaries and
branches to determine thrombus distribution and also adjacent
hepatic artery. Portal vein thrombi in the left portal vein were
evaluated using an anterior sub-xiphoid approach, and portal
vein thrombi in the right or main portal vein were evaluated
between the right and mid-clavicular line and the right poste-
rior axillary line using an inter-costal or subcostal approach.
The ﬂow was categorized by spectral conﬁguration as pulsatile
or continuous. Pulsatile ﬂow was called subjectively when a
waveform had a marked difference between peak systolic
and end diastolic velocities. Waveforms with mild sinusoidal
variation in velocity such as that seen commonly in the portal
vein were interpreted as continuous obviously.
3.2. Triphasic CT examination of the liver with spleno-
portography
Triphasic CT abdomen and pelvis was performed using
MDCT scanner 16 detectors (CT Bright Speed, GE Health-
care, Waukesha, WI, USA) scanner.. (A) B-mode and (B) color Doppler of the portal vein shows
nsformation) (yellow arrow). (C) Axial Triphasic CT of the liver
ed PV (red arrow) with cavernous transformation (yellow arrow).
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 One hour before scanning, patients received oral contrast
medium for GIT opaciﬁcation. Via a power injector,
150 mL of Omnipaque 300 mg I/ml (iohexol 300 mg I/ mL;
Nycomed, Princeton, NJ) was injected at a rate of 4 mL/s.
Double arterial phase scanning consisting of early and late
arterial phase image acquisition was performed during a
single breath-hold using respectively, 20 and 35 s scanning
delays from initiation of contrast material injection. We
elected to perform these two phases during a single
breath-hold to minimize the effect of variation on lesion
conspicuity and detection.
 The entire liver was scanned in a cephalocaudal direction
using detector collimation of 5 mm with a table speed/
rotation of 15 mm/0.8 s, and an image thickness of 5 mm.
 After a brief period of quiet breathing, portal venous phase
was performed using scanning delay of 60 s and an imageFig. 2 Male patient 55 y presented by right hypochondrium pain wi
Doppler assessment of the portal vein showing thrombosed right main
the thrombus. (B) Axial Triphasic CT, arterial phase, revealed heteroge
arrow) with enhanced right main portal thrombus (yellow arrow). (C)
the right hepatic lobe hepatic focal lesion (red arrow), as well as the
diameter is 27.7 mm. (D) 2D spleno-portography showing thrombosethickness of 5 mm. The scanning parameters used were
120 kV and 150–250 mAs.
 Portography was done by 2D Coronal reconstruction in
portal venous phase and MIP is the optimal technique for
displaying portography.
3.3. Diffusion weighted MRI (DWI)
MR imaging of the liver was performed with 1.5-TMR scanner
(Philips Achieva, Philips Healthcare) equipped with phased-
array torso surface coil. The examination included axial SPAIR
as well as DW sequences as different b-values (0, 500 and
1000 s/mm2), followed by computer-generated ADC mapping
of the liver. The use of diffusion weighted single-shot echo-
planar (DW SS-EP) sequences with a low b-value is important
for the detection of hepatic focal lesions, especially for
small-sized lesions. Diffusion sequences were performed
with the following parameters: TR = 1R-R, TE = 40 ms,th attacks of hematemesis and hepatic encephalopathy. (A) Color
portal vein branch with mono-phasic pulsatile ﬂow detected within
neously enhanced hepatic focal lesion at the right hepatic lobe (red
Axial CT porto-venous phase revealed wash-out of contrast from
thrombus within the right main PV (yellow arrow), the thrombus
d right main PV branch.
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angle = 90, acceleration factor = 2, FOV 32–44 cm.
ADC measurement: Pixel-based ADC maps were generated
on the workstation (PHILIPS). ADC was calculated with lin-
ear regression analysis of the function S= S0  exp
(b  ADC), where S is the signal intensity after application
of the diffusion gradient, and S0 is the signal intensity at a b
value of 0 s/mm2. The three b values (0, 500, and 1000 s/mm2)
were used for ADC calculation.
4. Histopathology
The conﬁrmation of neoplastic PVT done by FNAC from
thrombus which is performed in 33 patients out of 50 of ourFig. 3 Female patient 46 y presented with attack of hematemesis a
revealed thrombosed right main PV. (C) Axial and (D) Coronal Trip
arrow) inﬁltrating the right main PV with right main PV enhanced
thrombosed right main PV branch.study patients who were highly suspected to have malignant
PVT (based on elevated alpha fetoprotein, Doppler (pulsatile
ﬂow) and tri-phasic CT (intrathrombus neovascularization,
direct tumor invasion, early arterial thrombus enhancement,
increased dimension of PVT > 23 mm and adjacent HCC)
characteristics), while remaining 17 cases who showed normal
values of alpha fetoprotein with routine US and Triphasic CT
benign characteristics were excluded from FNAC.
 Aspiration samples were taken from thrombi located in
the intrahepatic portion of PV. FNAC was performed
using 22 Gauge Chiba Needle under continuous color
Doppler sonographic guidance with local anesthetic
(1% Lidocaine).nd encephalopathy. (A and B) US and color Duplex assessment
hasic CT showed large sized heterogeneous right lobe mass (red
thrombus (yellow arrow). (E) 2D spleno-portography showing
392 N.M.M. Osman, L.A.M. Samy FNAC was achieved from thrombus that was nearest to the
hepatic mass and most suspicious ones on color Doppler
US.
 FNAC technique; *Gray scale localization of an intrahep-
atic segment of thrombosed PV.
 The choice of biopsy path avoids hepatic artery and other
major vessels. The route for portal vein biopsy must avoid
segments of liver involved by tumor to prevent false-
positive results.
 Removal of needle stylet and connection of syringe for
aspiration. *Aspiration as the needle was removed with care
taken to keep the needle within the lumen of PV.
 The histopathological results of aspirated sample were
recorded.
 The color Doppler US, tri-phasic CT ﬁndings and MR
DWI of PVT were compared and correlated with
histopathological results in the patients who had performed
FNAC.
Statistical presentation and analysis of this study were con-
ducted using Chi-square tests by SPSS V 17.
Image Interpretation: Two independent reviewers with
experience in abdominal imaging reviewed the images indepen-
dently. All patients undergo real time US and color Doppler
for detection of the presence or absence of pulsatile ﬂow and
hepatic focal lesions, followed by Triphasic CT for the
Neovascularity, arterial enhancement, direct invasion and
thrombus diameter. MR DWI was done for more conﬁrma-
tion. The reviewers recorded the size of the HCC, closestFig. 4 Male patient 60y presented by jaundice and upper abdomina
main portal vein. (B) Triphasic CT examination, arterial and (C) porto-
no appreciable contrast enhancement (green transverse arrow) and left
DWI and ADC showed hepatic focal lesion (with restricted diffusion
intensity with hyperintense signal at DWI and hypointense signal at AD
and PV thrombus.distance between the HCC and PVT, diameter of the thrombus
and distribution of thrombus. DW images were reviewed for
the signal intensity of the PVT (hyperintense, isointense, or
hypointense to liver) and the mean apparent diffusion coefﬁ-
cient (ADC) of the PVT, HCC, and unaffected liver, which
were calculated by placing regions of interest on ADC map.
5. Results
This prospective study was conducted on 50 patients presented
with ultrasonic evidence of PVT referred to Radiodiagnosis
Department for color Doppler US and tri-phasic CT to dis-
criminate benign from malignant PVT.
Color Doppler, tri-phasic CT and MR DWI of PVT were
performed for all 50 patients and also alpha fetoprotein was
evaluated.
FNAC was selectively performed for only 33 patients who
were highly suspicious of malignant PVT (based on elevated
alpha fetoprotein (>400 IU/ml), with US and tri-phasic CT
characteristics of malignant PVT and HCC), while other 17
patients with normal alpha fetoprotein (<400 IU/ml) and with
routine US and tri-phasic characteristics of benign PVT, were
excluded from FNAC.
5.1. Demographic data
Patients’ age ranged from 45 to 60 years old. Mean age in the
ﬁrst group was 51.7+/9.3, and mean age in the second groupl pain. (A) US revealed thrombosed main PV extending to the left
venous phases revealed ill-deﬁned left lobe hepatic focal lesion with
main portal vein thrombus (oblique green arrow). (D) and (E) MR
) at the left hepatic lobe and left PV branch thrombus of same
C (red arrows). (F) SPAIR sequence revealed left lobe focal lesion
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pathology.
Two cases (2%) in this study had healthy hepatic parench-
yma (non-cirrhotic) and the remaining cases (98%) were cir-
rhotic patients.5.2. Gray scale and color Doppler examination
Depending on the US (real-time and color Doppler) examina-
tion of group I (17 patients) we found that 15 (88.23%) out ofFig. 5 Male patient 62 y old presented by right hypochondrium
(mean = 939.82). (B) DWI and ADC of PVT (mean = 989.31). D) D
intense signal) as well as PVT.17 patients had liver cirrhosis and 2 patients were not cirrhotic,
PVT was detected in the main PV in 17 patients (100%), in the
right branch in 3 patients (17.6%) and left branch in 1 patient
(5.8%) as shown in Table 1, Fig. 1.
In Group II (33 patients) we found that all patient had liver
cirrhosis and hepatic mass (33/33) (100%), and the hepatic
mass was multicenteric in (18/33) (54.54%) and solitary in
(15/33) (45.45%) (Figs. 2, 4 and 5). The PV thrombus
involvement was detected in the main PV in 27/33 patients
(81.81%, in the right PV branch in 17/33 (51.51%) patients
and left PV branch in 4/33 (12.12%) patients) with nopain, jaundice. (A) DWI and ADC of hepatic focal lesion
WI showing left lobe focal lesion with restricted diffusion (hyper
394 N.M.M. Osman, L.A.M. Samysigniﬁcant P-value. Intra thrombus pulsatile ﬂow was detected
in 25/33 (75.75%) patients shown in Table 1, Fig. 2.
5.3. Triphasic CT findings shown in Table 2
By Triphasic CT examination of group II (33 patients) we
found that Neovascularity of the PV thrombus was detected
in 28 out 33 patients (84.84%), arterial enhancement with
rapid washout in 29/33 (87.87%) patients, direct invasion by
adjacent hepatic mass in 25/33 (75.75%) and the diameter of
the thrombus was >23mmin 25/33 (75.75%) (Figs. 2 and 3).
Hepatic mass revealed early arterial enhancement with
rapid washout in all patients (33/33) (100%), and the hepatic
mass was solitary in 3/33 (9.09%) patients, multicenteric inFig. 6 55 years old male presented by repeated attacks of hematem
revealed thrombosed right main branch. (B) Triphasic CT arterial and (
(red arrow) with marked perfusion defect involving most of the righ
enhanced hepatic focal lesion detected. (E) MRI and DWI showed smal
main portal vein (yellow arrow).28/33 (84.84%) patients and diffuse in 2/33 (6.06%) patients
with signiﬁcant P-value (0.009) in differentiation (Figs. 2
and 3).
In this study we found that MDCT assessment has a signif-
icant p-value in diagnosis of malignant PVT, with a sensitivity
of 91.7%, 100% speciﬁcity and 94% accuracy.
5.4. MR DWI findings
MR DWI adds value in detection of hepatic mass for those
patients with perfusion defect in Triphasic CT examination
as shown in Fig. 6.
ADC values for group I (17 patients) was as follows:
mean ± SD (1.1  103 ± 0.1) and median (1.2), while theesis, jaundice associated with encephalopathy. (A) Color Doppler
C) porto-venous phases showed thrombosed right main PV branch
t lobe, more evident at the porto-venous phase, and no deﬁnite
l hepatic focal lesion with restricted diffusion very close to the right
Fig. 7 Receiver operating characteristic (ROC curve) analysis
for the ADC values to differentiate portal vein thrombus.
Table 3 MR DWI ﬁndings of our 50 patients.
MRI DWI ﬁndings Group I
(benign
cases)
N= 17
Group II
(malignant
cases) N= 33
P
value
No (%) No (%)
(1) Hepatic focal lesion
No HFL 17 100% 0 0% 0.008
Yes 0 0% 33 100%
(2) Signal intensity (SI) of
HFL
No
abnormal
signal
Hyper intense
signal
(3) ADC value of PVT and HFL
P1 14 (82.4%) 0 (0.0%) 0.001
<1 3 (17.6%) 33 (100%)
(4)a Size of hepatic focal lesion
(>5 cm) No HFL 30 90.9 0.002
(<5 cm) 3 9.09%
(5)a Distant of PVT from HFL
(<2 cm) No HFL 28 84.84% 0.006
(>2 cm) 5 15.15%
(6) PV thrombus diameter
according to Catalano
et al. (13)b
17 (100%) 33 (100%) 0.008
a 4,5 Criteria; Distance of PVT from tumor less than 2 cm, HCC
size of greater than 5 cm according to Shah et al. (15) criteria.
b Catalano et al. (13) considered PVT as malignant if the portal
vein caliber was larger than 1.8 cm for the main or left portal veins
and larger than 1.6 cm for the right portal vein or if there was
evidence of clear enhancement (>15%) of thrombus. PVTs that
lacked both criteria were deemed to be bland.
Table 4 Correlation of Triphasic CT, color Doppler with
histopathology./laboratory.ﬁndings.
Imaging modality No. of
patients
Sensitivity
(%)
Speciﬁcity
(%)
P
value
CT findings
Neovascularity of
the thrombus
28/33 84.84 100 0.004
Arterial
enhancement
29/33 87.87 100
Direct invasion by
tumor
25/33 75.75 100
Doppler finding (pulsatile flow)
Detected 25 75 100 0.002
Non detected 8
Table 5 The apparent diffusion coefﬁcient values of the
malignant and benign lesions.
ADC values
(103 mm2/s)
Group I
(benign cases)
N= 17
Group II
(malignant cases)
N= 33
P
value
Mean ± SD 1.1 ± 0.1 0.7 ± 0.1 0.001
Median 1.2 0.8
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(0.7  103 ± 0.1) and median (0.8) with signiﬁcant P value
(0.001). ROC curve analysis for diagnosing malignant PVT
yielded AUCs of 0.98 ± 0.01 for DW MRI, cutoff value
(61) (Fig. 7), sensitivity (100%), speciﬁcity (82.5%), PPV(94%), NPV (100%), accuracy (94%) and (P value 0.001) as
shown in Tables 5 and 6. Three patients (17.6%) with benign
PVT revealed overlap of the ADC values <1.
The signal intensities were high and apparent diffusion
coefﬁcient (ADC) values of portal vein thrombi were similar
to those of coexisting HCC in cases of neoplastic thrombosis
(33 cases), whereas DW imaging signal intensities were lower
and ADC values were high in cases of bland thrombosis
(17 cases) Figs. 4–6.
The size of the detected hepatic focal lesion was more than
5 cm in 30 cases (90.9%) and less than 5 cm in 3 cases (9.09%).
The distance of the hepatic focal lesion from the thrombosed
PV was less than 2 cm in 28 cases (84.84%) and more than
2 cm in 5 cases (15.15%) as shown in (Table 3). Mean diameter
of the PVT was less than 16 mm in benign PVT cases and
>18 mm in malignant PVT as shown in Table 3.
6. Discussion
The importance of neoplastic and bland portal vein thrombo-
sis discrimination is well recognized. The prevalence of PVT in
patients with cirrhosis has been reported more frequently in
recent years (15,16) (see Table 4).
The main pathogenic factor of PVT in cirrhosis is the
obstruction of the portal ﬂow, but acquired and inherited clot-
ting abnormalities may play a role. The formation of collateral
veins allows many patients to remain asymptomatic and pre-
vents the onset of clinical complications (17). In the current
study the liver cirrhosis was present in 33 patients with malig-
nant PVT (33/33) (100%) and in 15 patients out of 17 patients
with benign PVT (15/17) (88.23%).
HCC invasion into the portal vein renders a patient unsuit-
able for aggressive treatment approaches such as surgical
Table 6 Analysis of ADC values.
Variable AUC P value Cutoﬀ value Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%) Accuracy (%)
ADC 0.98 ± 0.01 0.001 61 100 82.5 91.7 100 94
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tion, due to the unusually high incidence of tumor recurrence
and dismal survival associated with these ﬁndings (18). In
our study we found that all 33 patients with malignant PVT
were suffering from HCC (100%), and tumor invasion of PV
was detectable in 25 patients out of 33 patients with malignant
PVT (75.7%).
The diagnosis of PVT has become easier than before
because of the availability of real time sonography. However,
the gray scale sonographic appearance of the thrombus is not
speciﬁc and cannot distinguish benign from malignant
thrombi. The use of Doppler sonography in the diagnosis of
malignant portal vein thrombosis has been evaluated by
several studies as non-visualization of portal vein ﬂow and
pulsatile ﬂow in the thrombus (19).
In our study we found that out of those 50 patients with
PVT, 33 patients were proved to be malignant PVT through
FNAC (66%) and the remaining 17 patients were benign
PVT (34%). On color Doppler US we found that out of 33
patients with malignant PVT, 25 patients were having intra-
thrombus arterial pulsatile ﬂow (25/33) (75.75%), while the
17 patients with benign PVT had not intra-thrombus pulsatile
ﬂow, with 100% speciﬁcity. This was in agreement with results
of the study by Pozniak and Baus (20), Mohammed (21), Rossi
et al. (22), and Tarantino et al. (23) who stated that all patients
with benign PVT had not intrathrombus pulsatile ﬂow with
100% speciﬁcity.
In the study by Dodd et al. (24) they found that out of 47
patients with PVT, 26 patients were proved to be malignant
through CT and histopathological ﬁndings and 21 patients
proved to be benign. Intrathrombus pulsatility was detected
in 16 patients with malignant PVT (16/26) (61.5%) and only
detected in 3 patients with benign PVT (3/21) (14.3%).
Triphasic CT is one of the best means of diagnosis of PV
thrombus and evaluation of various causative diseases (25).
In our study we found that on tri-phasic CT of the 33
patients with malignant PVT, 28 (84.8%) patients showed neo-
vascularity of PVT, early arterial enhancement and rapid
washout of the thrombus (29/33) (87.8%) and none of the 17
patients with benign PVT showed intrathrombus neovascular-
ity or enhancement. So triphasic CT had sensitivity of 87.8%,
speciﬁcity of 100% and accuracy of 93.3% in characterizing
malignant PVT. Our results were in agreement with those of
Lee et al. (26) and Piscaglia et al. (27) who considered neovas-
cularity sign is 100% speciﬁc for malignant PVT. Also we
found that out of 33 patients with malignant PVT 25 patients
showed PVT dimension (>23 mm) with sensitivity of 75.7%,
speciﬁcity of 100% and accuracy of 86.6%.
25 patients out of 33 showed direct invasion of thrombus by
HCC (75.7%) while this CT sign was not detectable in any one
of the 17 patients who had benign PVT associating HCC with
speciﬁcity of about 100%. This is matching with that reported
by Tublin et al. (28). Consequently, if a neovascularity, throm-
bus enhancement, thrombus diameter P23 mm, or directinvasion of the thrombus by tumor (either alone or combined)
were detected by CT then the speciﬁcity for the diagnosis of
malignant PVT approaches 100%.
A recent study concluded that quantitative measurements
from diffusion-weighted imaging (DWI) were highly accurate
in differentiating PVT (29–31).
In this study ADC values for group I (17 patients) were as
follows: mean ± SD (1.1  103 ± 0.1) and median (1.2),
while the ADC values for group II (33 patients) were
mean ± SD (0.7  103 ± 0.1) and median (0.8) with signiﬁ-
cant P value (0.001). ROC curve analysis for diagnosing
malignant PVT yielded AUCs of 0.98 ± 0.01 for DW MRI,
cutoff value (61), sensitivity (100%), speciﬁcity (82.5%),
PPV (94%), NPV(100%), accuracy (94%) and (P value
0.001). This is in agreement with Sandrasegaran et al. (14)
who concluded that ROC curve analysis for diagnosing malig-
nant PVT yielded AUCs of 0.92 and 0.91 for conventional
MRI and 0.69 and 0.64 for ADC values. Also Catalano
et al. (13) concluded that the mean ADC± standard deviation
of HCC and portal vein thrombus and mean ADC ratios in the
neoplastic thrombus group were 0.87  10–3 mm2/s ±
0.17  10–3, 0.88  10–3 mm2/s ± 0.19  10–3, and 0.998 ±
0.057, respectively. The respective values in the bland
thrombus group were 1.0  10–3 mm2/s ± 0.18  10–3,
2.89  10–3 mm2/s ± 0.76  10–3, and 2.913 ± 0.631.
Li et al. (32) concluded that 20 of 22 neoplastic PVT were
judged similar SI (signal intensity) and 2 were judged lower
SI than their HCC. For 20 bland PVT, 19 were judged lower
SI and 1 was judged similar SI as their HCC (P< 0.001).
The AUC for phase values in differentiating bland from neo-
plastic PVT was 0.989. The best cutoff value was 0.195,
which gave a sensitivity of 95% and a speciﬁcity of 95.5%.
Shah et al. (15)), concluded that a thrombus was considered
neoplastic if either of the following criteria was met and bland
if neither of the criteria was met: (a) expansion of the involved
vessel (vessel diameter P1.8 cm) for the main portal vein; (b)
Tumor size >5 cm and distance <2 cm; (C) The DW SI and
ADC values of neoplastic portal vein thrombi were similar
to those of the coexisting HCC, whereas the ADC values of
bland thrombi measured higher than those of the HCC. The
HCC and malignant PVT display similar SI on DW images
We decided to rely on imaging criteria as the reference stan-
dard in PVT differentiation, because ﬁne-needle aspiration
cytology is an invasive procedure with associated risks of
bleeding.
7. Conclusion
The combination of color Doppler US, tri-phasic CT and MR
DWI is essential for more accurate evaluation and differentia-
tion of benign from malignant PVT. The speciﬁcity and sensi-
tivity of color Doppler intra-thrombi pulsatile ﬂow reach
75.7% and 100% respectively. Triphasic CT had sensitivity
of 87.8%, speciﬁcity of 100% and accuracy of 94%. DWI
Benign and malignant portal vein thrombosis: Multi-modality imaging evaluation 397imaging enables improved detection and discrimination
between bland and malignant PVT with sensitivity (100%)
and speciﬁcity (82.5%). DW imaging can be an alternative to
CT in patient with contraindication to contrast media.
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